共 6 条
[1]
Food and Drug Administration, FOOD DRUG ADM GUID I
[2]
The EGALITY study: a confirmatory, randomized, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate-to-severe chronic plaque-type psoriasis
[J].
BRITISH JOURNAL OF DERMATOLOGY,
2017, 176 (04)
:928-938